Gautham Chakra R, Chandana Sai Y, Jyoshna V, Likhitha K, Tejeswini N, Iswarya N, Naga Lakshmi N
{"title":"三级医院冠心病处方模式","authors":"Gautham Chakra R, Chandana Sai Y, Jyoshna V, Likhitha K, Tejeswini N, Iswarya N, Naga Lakshmi N","doi":"10.26452/fjphs.v3i4.525","DOIUrl":null,"url":null,"abstract":"The study aims to assess the current prescribing patterns for drugs managing Coronary Heart Disease (CHD) at the designated site to promote rational drug use in a specialized population. Conducted in the Medicine ward over six months, this observational retrospective study focused on patients consulting cardiologists for cardiac issues. Among lipid-lowering agents, rosuvastatin was the most prescribed (52.84%), followed by atorvastatin (43.15%). Anti-hypertensive agents were widely used, with beta-blockers, ACE inhibitors, and diuretics being popular choices. Adrenergic receptor blockers were common for hypertension, with metoprolol (55.7%) and bisoprolol (10.8%) frequently prescribed. ACE inhibitors, particularly Enalapril (65.6%), dominated prescriptions. Diuretics, including eplerenone (37.2%) and furosemide (33.3%), ranked third. The majority of patients were male, potentially linked to smoking and alcohol habits. Analysis revealed the prevalence of statins and anti-atherogenic agents in cardiovascular prescriptions. Beta-blockers, ACE inhibitors, and diuretics were prominent in managing hypertension.Top of Form","PeriodicalId":503124,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"66 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The prescription pattern for coronary artery disease in tertiary care hospitals\",\"authors\":\"Gautham Chakra R, Chandana Sai Y, Jyoshna V, Likhitha K, Tejeswini N, Iswarya N, Naga Lakshmi N\",\"doi\":\"10.26452/fjphs.v3i4.525\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The study aims to assess the current prescribing patterns for drugs managing Coronary Heart Disease (CHD) at the designated site to promote rational drug use in a specialized population. Conducted in the Medicine ward over six months, this observational retrospective study focused on patients consulting cardiologists for cardiac issues. Among lipid-lowering agents, rosuvastatin was the most prescribed (52.84%), followed by atorvastatin (43.15%). Anti-hypertensive agents were widely used, with beta-blockers, ACE inhibitors, and diuretics being popular choices. Adrenergic receptor blockers were common for hypertension, with metoprolol (55.7%) and bisoprolol (10.8%) frequently prescribed. ACE inhibitors, particularly Enalapril (65.6%), dominated prescriptions. Diuretics, including eplerenone (37.2%) and furosemide (33.3%), ranked third. The majority of patients were male, potentially linked to smoking and alcohol habits. Analysis revealed the prevalence of statins and anti-atherogenic agents in cardiovascular prescriptions. Beta-blockers, ACE inhibitors, and diuretics were prominent in managing hypertension.Top of Form\",\"PeriodicalId\":503124,\"journal\":{\"name\":\"Future Journal of Pharmaceuticals and Health Sciences\",\"volume\":\"66 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Journal of Pharmaceuticals and Health Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26452/fjphs.v3i4.525\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceuticals and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26452/fjphs.v3i4.525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The prescription pattern for coronary artery disease in tertiary care hospitals
The study aims to assess the current prescribing patterns for drugs managing Coronary Heart Disease (CHD) at the designated site to promote rational drug use in a specialized population. Conducted in the Medicine ward over six months, this observational retrospective study focused on patients consulting cardiologists for cardiac issues. Among lipid-lowering agents, rosuvastatin was the most prescribed (52.84%), followed by atorvastatin (43.15%). Anti-hypertensive agents were widely used, with beta-blockers, ACE inhibitors, and diuretics being popular choices. Adrenergic receptor blockers were common for hypertension, with metoprolol (55.7%) and bisoprolol (10.8%) frequently prescribed. ACE inhibitors, particularly Enalapril (65.6%), dominated prescriptions. Diuretics, including eplerenone (37.2%) and furosemide (33.3%), ranked third. The majority of patients were male, potentially linked to smoking and alcohol habits. Analysis revealed the prevalence of statins and anti-atherogenic agents in cardiovascular prescriptions. Beta-blockers, ACE inhibitors, and diuretics were prominent in managing hypertension.Top of Form